Evidence map›Paper›PMID 36035369›Full record

ArticleInternational journal of medical sciences2022

Comprehensive Analysis of Transcriptional Expression of hsa-mir-21 Predicted Target Genes and Immune Characteristics in Kidney Renal Clear Cell Carcinoma.

Da-Ming Xu, Ming Li, Shu-Bin Lin, Zheng-Liang Yang, Teng-Yu Xu, Jin-Huan Yang, Jun Yin

Open access · goldAbstract read
In one paragraph

Article in International journal of medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Da-Ming XuDepartment of Urological Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Ming LiDepartment of Urological Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Shu-Bin LinDepartment of Urological Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Zheng-Liang YangDepartment of Urological Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Teng-Yu XuDepartment of Urological Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Jin-Huan YangDepartment of Urological Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Jun YinDepartment of Hematology, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Shantou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsMicroRNAsBiomarkers, TumorHumansKidneyPrognosisTranscription FactorsBiomarkers, TumorMicroRNAsMIRN21 microRNA, humanTranscription FactorsHsa-mir-21Immune CharacteristicsKidney Renal Clear Cell CarcinomaPredicted Target GenePrediction ModelPrognosisTranscription Factor

Identifiers

PMID36035369
PMCPMC9413563
OpenAlexW4293109975

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.